ACUTUS MEDICAL INC(AFIB)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- IV Rank (30D)
- 0
- Straddle Price
- $2.40
- P/C Vol Ratio
- 0.00
- Exchange
- OTC Link
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -3.74% | 4 |
| Feb | -10.18% | 4 |
| Mar | -8.55% | 4 |
| Apr | -0.12% | 4 |
| May | -10.33% | 4 |
| Jun | +21.93% | 3 |
| Jul | +11.37% | 3 |
| Aug | -17.26% | 3 |
| Sep | -2.95% | 3 |
| Oct | -14.00% | 3 |
| Nov | -36.58% | 3 |
| Dec | +6.00% | 3 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-08 | unknown | 7804.88% | 0.81% | 0.00x | Within |
- IV Rank (30D)
- 0
- IV Rank (7D)
- 0
- Avg IV
- 0.0%
- Straddle (30D)
- $2.40
- Straddle (7D)
- $2.40
- P/C Volume
- 0.00
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2024-03-04 | Takeo Mukai | CFO | Tax (F) | −8,475 | $0.21 | -$1.8K | EDGAR |
| 2024-02-07 | Tom Sohn | SVP, Gen. Counsel & Secretary | Tax (F) | −7,582 | $0.17 | -$1.3K | EDGAR |
| 2024-02-02 | Takeo Mukai | CFO | Tax (F) | −2,869 | $0.19 | -$548 | EDGAR |
| 2024-02-02 | Tom Sohn | SVP, Gen. Counsel & Secretary | Tax (F) | −5,709 | $0.19 | -$1.1K | EDGAR |
| 2024-01-18 | David Roman | President & CEO | Tax (F) | −24,086 | $0.19 | -$4.6K | EDGAR |
| 2024-01-18 | Kevin Mathews | SVP, Commercial | Tax (F) | −6,342 | $0.19 | -$1.2K | EDGAR |
| 2023-09-05 | Takeo Mukai | CFO | Tax (F) | −1,729 | $0.49 | -$844 | EDGAR |
| 2023-08-07 | Tom Sohn | SVP, Gen. Counsel & Secretary | Tax (F) | −433 | $0.69 | -$299 | EDGAR |
| 2023-08-07 | Kevin Mathews | SVP, Commercial | Tax (F) | −134 | $0.69 | -$92 | EDGAR |
| 2023-08-02 | David Roman | President & CEO | Tax (F) | −6,484 | — | EDGAR | |
| 2023-08-02 | Tom Sohn | SVP, Gen. Counsel & Secretary | Award (A) | +20,000 | — | EDGAR | |
| 2023-08-02 | Takeo Mukai | CFO | Tax (F) | −501 | — | EDGAR | |
| 2023-06-29 | Andrew ElBardissi | Director | Award (A) | +8,400 | — | EDGAR | |
| 2023-06-20 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director | Award (A) | +33,600 | — | EDGAR | |
| 2023-06-15 | Niamh Louise Pellegrini | Director | Award (A) | +8,400 | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David P Bonita | Director | 1,698,183 | $152.8K | $22.47M | 6 | 2023-06-15 |
| 2 | DEERFIELD MANAGEMENT COMPANY, L.P. | Director | 1,026,243 | $92.4K | $252.00M | 4 | 2023-06-20 |
| 3 | R Scott Huennekens | Director | 529,349 | $47.6K | -$34.8K | 4 | 2023-06-15 |
| 4 | David Roman | President & CEO | 332,134 | $29.9K | $0 | 11 | 2024-01-18 |
| 5 | Tom Sohn | SVP, Gen. Counsel & Secretary | 105,009 | $9.5K | $0 | 9 | 2024-02-07 |
| 6 | Charlie Piscitello | SVP, Chief People Officer | 85,683 | $7.7K | $0 | 5 | 2023-04-04 |
| 7 | James F. Hinrichs | Director | 76,310 | $6.9K | $331.2K | 5 | 2022-06-21 |
| 8 | Takeo Mukai | CFO | 72,874 | $6.6K | $0 | 7 | 2024-03-04 |
| 9 | Shahzad Malik | Director | 69,458 | $6.3K | $0 | 3 | 2021-06-22 |
| 10 | Vincent J Burgess | Chief Executive Officer | 61,469 | $5.5K | $0 | 4 | 2022-04-05 |
| 11 | Kevin Mathews | SVP, Commercial | 61,106 | $5.5K | $0 | 7 | 2024-01-18 |
| 12 | Steven McQuillan | SVP, Clinical Affairs & QA | 45,844 | $4.1K | $0 | 4 | 2022-04-05 |
| 13 | John F Sheridan | Director | 24,347 | $2.2K | $0 | 3 | 2023-06-15 |
| 14 | Jason K Garland | Director | 22,400 | $2.0K | $0 | 2 | 2023-06-15 |
| 15 | Niamh Louise Pellegrini | Director | 20,972 | $1.9K | $0 | 3 | 2023-06-15 |
| 16 | Andrew ElBardissi | Director | 20,822 | $1.9K | $0 | 5 | 2023-06-29 |
| 17 | Shaden Marzouk | Director | 20,822 | $1.9K | $0 | 4 | 2023-06-15 |
| 18 | John Barnickel | Chief Commercial Officer | 13,966 | $1.3K | $131.4K | 2 | 2020-08-12 |
| 19 | Daniella Cramp | Director | 11,623 | $1.0K | $0 | 2 | 2022-06-21 |
| 20 | Gary W. Doherty | Chief Financial Officer | 5,000 | $450 | $0 | 1 | 2020-08-07 |
| 21 | Orbimed ROF II LLC | Director | 4,022 | $362 | $67.41M | 2 | 2021-07-21 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.